data_2i8f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i8f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 N--CA 1.509 2.508 0 CA-C-O 119.171 -0.442 . . . . 1.98 111.652 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.42 156.92 18.01 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 119.307 0.958 . . . . 2.04 111.207 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.88 -34.94 73.12 Favored Glycine 1 N--CA 1.52 4.282 0 CA-C-O 119.322 -0.71 . . . . 1.1899999999999999 113.254 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -41.16 76.46 Favored 'General case' 0 N--CA 1.53 3.526 0 CA-C-N 118.793 1.296 . . . . 1.53 110.117 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 -35.05 39.9 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 122.2 -0.312 . . . . 1.3200000000000001 110.816 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.84 -32.76 67.86 Favored 'General case' 0 N--CA 1.525 3.283 0 CA-C-N 118.346 0.521 . . . . 1.8200000000000001 110.477 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -64.89 -33.54 76.25 Favored 'General case' 0 N--CA 1.527 3.415 0 CA-C-N 118.484 0.584 . . . . 0.52000000000000002 110.064 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -90.01 -34.04 16.13 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-N 117.97 0.35 . . . . 2.3700000000000001 110.272 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.9 m -73.22 -53.59 10.54 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 118.535 0.607 . . . . 0.5 109.857 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -77.79 159.12 77.14 Favored Pre-proline 0 N--CA 1.525 3.293 0 N-CA-C 109.102 -0.703 . . . . 1.4199999999999999 109.102 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.72 65.17 7.56 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 122.164 1.909 . . . . 0.52000000000000002 111.257 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.4 m -105.62 -43.86 4.82 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 108.328 -0.99 . . . . 0.31 108.328 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.13 -18.83 64.81 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.627 0.603 . . . . 0.90000000000000002 112.627 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.83 89.16 Favored 'General case' 0 N--CA 1.528 3.429 0 CA-C-N 119.176 0.898 . . . . 0.97999999999999998 110.697 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -98.61 -44.2 6.54 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 109.425 -0.583 . . . . 0.26000000000000001 109.425 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -79.83 158.08 26.87 Favored 'General case' 0 N--CA 1.526 3.372 0 CA-C-O 121.128 0.49 . . . . 0.39000000000000001 111.858 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.59 175.59 8.44 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 109.273 -0.64 . . . . 1.8100000000000001 109.273 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.98 -31.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 O-C-N 121.758 -0.589 . . . . 1.24 112.125 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.41 -61.91 1.3 Allowed 'General case' 0 N--CA 1.521 3.091 0 CA-C-N 119.125 0.875 . . . . 2.02 111.665 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 m -93.65 155.86 17.03 Favored 'General case' 0 N--CA 1.53 3.543 0 CA-C-N 118.482 0.583 . . . . 1.72 110.896 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -78.44 135.67 37.45 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.087 -0.383 . . . . 1.8300000000000001 110.208 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.9 mtt -99.41 -64.47 1.04 Allowed 'General case' 0 N--CA 1.522 3.132 0 N-CA-C 107.428 -1.323 . . . . 2.5099999999999998 107.428 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.49 -43.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.325 0 N-CA-C 108.498 -0.927 . . . . 1.1399999999999999 108.498 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.15 -149.79 11.12 Favored Glycine 0 N--CA 1.511 3.65 0 N-CA-C 108.991 -1.644 . . . . 0.57999999999999996 108.991 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.87 154.41 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.743 2.295 . . . . 0.35999999999999999 111.576 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.55 167.42 10.99 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 109.102 -0.703 . . . . 1.04 109.102 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.2 mt -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.528 3.46 0 O-C-N 121.651 -0.655 . . . . 1.26 109.715 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -66.29 -33.19 75.19 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 122.618 0.367 . . . . 2.0299999999999998 110.22 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.77 -48.15 48.66 Favored 'General case' 0 N--CA 1.524 3.238 0 CA-C-N 118.021 0.373 . . . . 1.3200000000000001 110.483 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.26 -31.51 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.37 0.532 . . . . 1.2 110.664 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.98 -31.87 50.99 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 118.003 0.365 . . . . 1.1000000000000001 110.374 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.5 -45.04 61.28 Favored 'General case' 0 N--CA 1.524 3.245 0 CA-C-N 118.224 0.466 . . . . 1.2 110.585 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -74.53 -47.3 33.68 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 109.048 -0.723 . . . . 2.79 109.048 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -112.39 93.69 4.56 Favored 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 107.244 -1.391 . . . . 1.8600000000000001 107.244 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.97 74.26 1.45 Allowed 'General case' 0 N--CA 1.518 2.962 0 CA-C-O 121.603 0.716 . . . . 1.4099999999999999 110.022 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.12 66.11 2.55 Favored Glycine 1 N--CA 1.518 4.1 0 N-CA-C 110.436 -1.066 . . . . 0.69999999999999996 110.436 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.4 143.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 CA-C-N 117.396 0.598 . . . . 1.5600000000000001 109.492 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.38 139.38 44.04 Favored 'General case' 0 N--CA 1.525 3.279 0 N-CA-C 108.576 -0.898 . . . . 2.8999999999999999 108.576 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.73 -47.26 1.11 Allowed Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.083 -2.007 . . . . 1.1699999999999999 108.083 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -38.83 88.13 Favored 'General case' 0 N--CA 1.518 2.973 0 CA-C-N 117.387 0.593 . . . . 1.01 109.574 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.66 83.61 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-N 118.221 0.464 . . . . 1.0700000000000001 110.228 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.46 -38.5 59.59 Favored 'General case' 0 N--CA 1.522 3.142 0 N-CA-C 109.614 -0.513 . . . . 1.5 109.614 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -69.83 -38.46 76.54 Favored 'General case' 0 N--CA 1.528 3.44 0 N-CA-C 109.236 -0.653 . . . . 1.1599999999999999 109.236 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.42 -35.88 68.46 Favored 'General case' 0 N--CA 1.523 3.215 0 N-CA-C 109.465 -0.569 . . . . 1.8700000000000001 109.465 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.04 66.79 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-N 117.97 0.35 . . . . 1.1399999999999999 110.075 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.82 -28.5 61.65 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 109.687 -0.486 . . . . 1.3999999999999999 109.687 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.48 83.17 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 122.756 0.422 . . . . 1.1200000000000001 110.643 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 pt -78.29 -23.01 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 122.049 -0.407 . . . . 1.1200000000000001 111.382 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -90.35 -32.33 16.52 Favored 'General case' 0 N--CA 1.52 3.025 0 CA-C-N 118.521 0.6 . . . . 1.8500000000000001 110.671 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -108.73 -58.83 1.96 Allowed 'General case' 0 N--CA 1.522 3.148 0 CA-C-N 118.693 0.678 . . . . 2.1400000000000001 110.096 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.97 148.99 5.27 Favored Glycine 1 N--CA 1.52 4.278 0 N-CA-C 110.719 -0.953 . . . . 0.44 110.719 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -105.72 141.93 36.31 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 122.27 -0.547 . . . . 0.46999999999999997 110.117 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -133.67 102.84 5.63 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 109.642 -0.503 . . . . 3.1299999999999999 109.642 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.78 79.82 0.3 Allowed Glycine 1 N--CA 1.517 4.065 0 O-C-N 121.757 -0.589 . . . . 0.55000000000000004 112.217 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.77 -42.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 CA-C-N 117.56 0.68 . . . . 1.0700000000000001 110.361 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -115.77 -52.27 2.63 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.507 0.594 . . . . 0.58999999999999997 109.92 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.07 -172.1 12.45 Favored Glycine 1 N--CA 1.517 4.077 0 N-CA-C 111.741 -0.544 . . . . 1.1399999999999999 111.741 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.95 -24.73 9.58 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.111 2.541 . . . . 1.55 112.728 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.52 129.05 73.02 Favored Pre-proline 0 N--CA 1.524 3.246 0 CA-C-O 118.31 -0.852 . . . . 1.73 109.448 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.74 164.83 9.07 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.785 2.323 . . . . 0.78000000000000003 110.83 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.8 ttp -120.38 131.64 24.38 Favored Pre-proline 0 N--CA 1.522 3.155 0 CA-C-O 118.648 -0.691 . . . . 1.0 109.429 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.52 172.19 15.61 Favored 'Trans proline' 0 CA--C 1.574 2.507 0 C-N-CA 122.681 2.254 . . . . 0.47999999999999998 110.58 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -71.88 110.39 2.9 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.235 1.956 . . . . 0.38 110.181 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -81.67 157.27 69.84 Favored Pre-proline 0 N--CA 1.524 3.231 0 CA-C-O 119.108 -0.472 . . . . 0.46000000000000002 110.817 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.33 99.9 1.31 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.502 2.134 . . . . 0.56999999999999995 109.761 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.1 133.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 N-CA-C 109.795 -0.446 . . . . 1.1699999999999999 109.795 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 p -89.83 -178.33 5.47 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.469 0.307 . . . . 1.6100000000000001 110.362 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.83 -44.84 84.36 Favored 'General case' 0 N--CA 1.527 3.424 0 O-C-N 121.697 -0.627 . . . . 1.97 110.699 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.79 -36.01 79.68 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-N 118.173 0.442 . . . . 1.1100000000000001 110.894 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.16 -38.13 66.32 Favored 'General case' 0 N--CA 1.521 3.114 0 N-CA-C 109.47 -0.567 . . . . 1.23 109.47 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.25 73.63 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 118.006 0.366 . . . . 1.0700000000000001 110.726 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -73.74 -40.8 63.26 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-N 118.297 0.499 . . . . 3.2599999999999998 109.738 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 53.6 mt -72.25 -38.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.849 -0.797 . . . . 2.1200000000000001 108.849 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -39.51 71.92 Favored 'General case' 0 N--CA 1.523 3.222 0 N-CA-C 109.491 -0.559 . . . . 2.3799999999999999 109.491 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.12 -41.92 85.35 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 118.179 0.445 . . . . 1.1599999999999999 110.101 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.4 -28.65 64.16 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 121.99 -0.444 . . . . 1.6200000000000001 110.557 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 31.6 t90 -77.5 -43.4 32.24 Favored 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 118.613 0.642 . . . . 0.62 110.274 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.91 -31.26 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 CA-C-N 118.838 0.744 . . . . 1.21 109.9 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.51 -49.54 16.25 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.609 -0.886 . . . . 1.45 108.609 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.2 m -118.05 97.35 5.77 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.655 -1.239 . . . . 1.52 107.655 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.88 156.38 22.45 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.895 -0.503 . . . . 1.3999999999999999 111.189 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm . . . . . 0 N--CA 1.517 2.922 0 CA-C-O 118.625 -0.702 . . . . 4.2800000000000002 109.51 179.736 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 N--CA 1.509 2.508 0 CA-C-O 119.171 -0.442 . . . . 1.8600000000000001 111.652 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.42 156.92 18.01 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 119.307 0.958 . . . . 2.04 111.207 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.88 -34.94 73.12 Favored Glycine 1 N--CA 1.52 4.282 0 CA-C-O 119.322 -0.71 . . . . 0.93000000000000005 113.254 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -41.16 76.46 Favored 'General case' 0 N--CA 1.53 3.526 0 CA-C-N 118.793 1.296 . . . . 1.53 110.117 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 -35.05 39.9 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 122.2 -0.312 . . . . 0.81999999999999995 110.816 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD23 HD23 ' A' ' 74' ' ' LEU . 2.9 tp -71.84 -32.76 67.86 Favored 'General case' 0 N--CA 1.525 3.283 0 CA-C-N 118.346 0.521 . . . . 1.1699999999999999 110.477 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -64.89 -33.54 76.25 Favored 'General case' 0 N--CA 1.527 3.415 0 CA-C-N 118.484 0.584 . . . . 0.52000000000000002 110.064 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -90.01 -34.04 16.13 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-N 117.97 0.35 . . . . 1.53 110.272 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.9 m -73.22 -53.59 10.54 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 118.535 0.607 . . . . 0.48999999999999999 109.857 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -77.79 159.12 77.14 Favored Pre-proline 0 N--CA 1.525 3.293 0 N-CA-C 109.102 -0.703 . . . . 0.81000000000000005 109.102 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' O ' HMC3 ' A' ' 83' ' ' HEC . 37.9 Cg_endo -76.72 65.17 7.56 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 122.164 1.909 . . . . 0.46000000000000002 111.257 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.4 m -105.62 -43.86 4.82 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 108.328 -0.99 . . . . 0.28999999999999998 108.328 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.13 -18.83 64.81 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.627 0.603 . . . . 0.40999999999999998 112.627 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.83 89.16 Favored 'General case' 0 N--CA 1.528 3.429 0 CA-C-N 119.176 0.898 . . . . 0.31 110.697 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -98.61 -44.2 6.54 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 109.425 -0.583 . . . . 0.23999999999999999 109.425 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -79.83 158.08 26.87 Favored 'General case' 0 N--CA 1.526 3.372 0 CA-C-O 121.128 0.49 . . . . 0.39000000000000001 111.858 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.59 175.59 8.44 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 109.273 -0.64 . . . . 1.4099999999999999 109.273 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.98 -31.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 O-C-N 121.758 -0.589 . . . . 0.51000000000000001 112.125 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.41 -61.91 1.3 Allowed 'General case' 0 N--CA 1.521 3.091 0 CA-C-N 119.125 0.875 . . . . 2.02 111.665 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 m -93.65 155.86 17.03 Favored 'General case' 0 N--CA 1.53 3.543 0 CA-C-N 118.482 0.583 . . . . 1.1499999999999999 110.896 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -78.44 135.67 37.45 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.087 -0.383 . . . . 1.1000000000000001 110.208 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.9 mtt -99.41 -64.47 1.04 Allowed 'General case' 0 N--CA 1.522 3.132 0 N-CA-C 107.428 -1.323 . . . . 1.95 107.428 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.49 -43.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.325 0 N-CA-C 108.498 -0.927 . . . . 0.53000000000000003 108.498 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.15 -149.79 11.12 Favored Glycine 0 N--CA 1.511 3.65 0 N-CA-C 108.991 -1.644 . . . . 0.5 108.991 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.87 154.41 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.743 2.295 . . . . 0.31 111.576 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.55 167.42 10.99 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 109.102 -0.703 . . . . 0.22 109.102 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.2 mt -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.528 3.46 0 O-C-N 121.651 -0.655 . . . . 0.48999999999999999 109.715 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -66.29 -33.19 75.19 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 122.618 0.367 . . . . 1.4099999999999999 110.22 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.77 -48.15 48.66 Favored 'General case' 0 N--CA 1.524 3.238 0 CA-C-N 118.021 0.373 . . . . 1.3200000000000001 110.483 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.26 -31.51 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.37 0.532 . . . . 0.46999999999999997 110.664 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.98 -31.87 50.99 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 118.003 0.365 . . . . 0.39000000000000001 110.374 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.5 -45.04 61.28 Favored 'General case' 0 N--CA 1.524 3.245 0 CA-C-N 118.224 0.466 . . . . 0.44 110.585 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -74.53 -47.3 33.68 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 109.048 -0.723 . . . . 2.3399999999999999 109.048 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -112.39 93.69 4.56 Favored 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 107.244 -1.391 . . . . 1.25 107.244 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.97 74.26 1.45 Allowed 'General case' 0 N--CA 1.518 2.962 0 CA-C-O 121.603 0.716 . . . . 0.65000000000000002 110.022 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.12 66.11 2.55 Favored Glycine 1 N--CA 1.518 4.1 0 N-CA-C 110.436 -1.066 . . . . 0.69999999999999996 110.436 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.4 143.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 CA-C-N 117.396 0.598 . . . . 1.0 109.492 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.38 139.38 44.04 Favored 'General case' 0 N--CA 1.525 3.279 0 N-CA-C 108.576 -0.898 . . . . 2.8999999999999999 108.576 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.73 -47.26 1.11 Allowed Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.083 -2.007 . . . . 0.62 108.083 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -38.83 88.13 Favored 'General case' 0 N--CA 1.518 2.973 0 CA-C-N 117.387 0.593 . . . . 0.40000000000000002 109.574 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.66 83.61 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-N 118.221 0.464 . . . . 0.42999999999999999 110.228 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.46 -38.5 59.59 Favored 'General case' 0 N--CA 1.522 3.142 0 N-CA-C 109.614 -0.513 . . . . 1.5 109.614 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -69.83 -38.46 76.54 Favored 'General case' 0 N--CA 1.528 3.44 0 N-CA-C 109.236 -0.653 . . . . 0.52000000000000002 109.236 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.42 -35.88 68.46 Favored 'General case' 0 N--CA 1.523 3.215 0 N-CA-C 109.465 -0.569 . . . . 1.21 109.465 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.04 66.79 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-N 117.97 0.35 . . . . 0.32000000000000001 110.075 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.82 -28.5 61.65 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 109.687 -0.486 . . . . 0.69999999999999996 109.687 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.48 83.17 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 122.756 0.422 . . . . 0.34000000000000002 110.643 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.424 HD12 HG11 ' A' ' 66' ' ' VAL . 42.1 pt -78.29 -23.01 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 122.049 -0.407 . . . . 0.35999999999999999 111.382 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -90.35 -32.33 16.52 Favored 'General case' 0 N--CA 1.52 3.025 0 CA-C-N 118.521 0.6 . . . . 1.27 110.671 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -108.73 -58.83 1.96 Allowed 'General case' 0 N--CA 1.522 3.148 0 CA-C-N 118.693 0.678 . . . . 1.6299999999999999 110.096 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.97 148.99 5.27 Favored Glycine 1 N--CA 1.52 4.278 0 N-CA-C 110.719 -0.953 . . . . 0.44 110.719 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -105.72 141.93 36.31 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 122.27 -0.547 . . . . 0.42999999999999999 110.117 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -133.67 102.84 5.63 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 109.642 -0.503 . . . . 2.48 109.642 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.78 79.82 0.3 Allowed Glycine 1 N--CA 1.517 4.065 0 O-C-N 121.757 -0.589 . . . . 0.47999999999999998 112.217 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.77 -42.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 CA-C-N 117.56 0.68 . . . . 0.40000000000000002 110.361 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -115.77 -52.27 2.63 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.507 0.594 . . . . 0.58999999999999997 109.92 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.07 -172.1 12.45 Favored Glycine 1 N--CA 1.517 4.077 0 N-CA-C 111.741 -0.544 . . . . 0.80000000000000004 111.741 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.95 -24.73 9.58 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.111 2.541 . . . . 1.29 112.728 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.463 ' O ' HMD1 ' A' ' 83' ' ' HEC . 38.7 mm -79.52 129.05 73.02 Favored Pre-proline 0 N--CA 1.524 3.246 0 CA-C-O 118.31 -0.852 . . . . 1.0 109.448 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.74 164.83 9.07 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.785 2.323 . . . . 0.68000000000000005 110.83 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.8 ttp -120.38 131.64 24.38 Favored Pre-proline 0 N--CA 1.522 3.155 0 CA-C-O 118.648 -0.691 . . . . 0.35999999999999999 109.429 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.52 172.19 15.61 Favored 'Trans proline' 0 CA--C 1.574 2.507 0 C-N-CA 122.681 2.254 . . . . 0.40999999999999998 110.58 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -71.88 110.39 2.9 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.235 1.956 . . . . 0.35999999999999999 110.181 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -81.67 157.27 69.84 Favored Pre-proline 0 N--CA 1.524 3.231 0 CA-C-O 119.108 -0.472 . . . . 0.46000000000000002 110.817 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.33 99.9 1.31 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.502 2.134 . . . . 0.47999999999999998 109.761 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 48' ' ' ILE . 12.7 p -151.1 133.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 N-CA-C 109.795 -0.446 . . . . 0.42999999999999999 109.795 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 p -89.83 -178.33 5.47 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.469 0.307 . . . . 0.96999999999999997 110.362 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.83 -44.84 84.36 Favored 'General case' 0 N--CA 1.527 3.424 0 O-C-N 121.697 -0.627 . . . . 1.97 110.699 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.79 -36.01 79.68 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-N 118.173 0.442 . . . . 1.1100000000000001 110.894 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.16 -38.13 66.32 Favored 'General case' 0 N--CA 1.521 3.114 0 N-CA-C 109.47 -0.567 . . . . 1.23 109.47 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.25 73.63 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 118.006 0.366 . . . . 0.46999999999999997 110.726 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -73.74 -40.8 63.26 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-N 118.297 0.499 . . . . 2.8100000000000001 109.738 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 53.6 mt -72.25 -38.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.849 -0.797 . . . . 1.45 108.849 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.439 HD23 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -71.14 -39.51 71.92 Favored 'General case' 0 N--CA 1.523 3.222 0 N-CA-C 109.491 -0.559 . . . . 1.6699999999999999 109.491 179.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.12 -41.92 85.35 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 118.179 0.445 . . . . 0.57999999999999996 110.101 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.4 -28.65 64.16 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 121.99 -0.444 . . . . 1.6200000000000001 110.557 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 31.6 t90 -77.5 -43.4 32.24 Favored 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 118.613 0.642 . . . . 0.54000000000000004 110.274 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.91 -31.26 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 CA-C-N 118.838 0.744 . . . . 0.48999999999999999 109.9 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.51 -49.54 16.25 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.609 -0.886 . . . . 0.83999999999999997 108.609 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.2 m -118.05 97.35 5.77 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.655 -1.239 . . . . 0.82999999999999996 107.655 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.88 156.38 22.45 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.895 -0.503 . . . . 1.1399999999999999 111.189 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm . . . . . 0 N--CA 1.517 2.922 0 CA-C-O 118.625 -0.702 . . . . 3.79 109.51 179.736 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HEC . . . . . 0.463 HMD1 ' O ' ' A' ' 59' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 N--CA 1.509 2.508 0 CA-C-O 119.171 -0.442 . . . . 1.86 111.652 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.42 156.92 18.01 Favored 'General case' 0 N--CA 1.533 3.689 0 CA-C-N 119.307 0.958 . . . . 2.04 111.207 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.88 -34.94 73.12 Favored Glycine 1 N--CA 1.52 4.282 0 CA-C-O 119.322 -0.71 . . . . 0.93 113.254 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.5 -41.16 76.46 Favored 'General case' 0 N--CA 1.53 3.526 0 CA-C-N 118.793 1.296 . . . . 1.53 110.117 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 -35.05 39.9 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 122.2 -0.312 . . . . 0.82 110.816 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD23 HD23 ' A' ' 74' ' ' LEU . 2.9 tp -71.84 -32.76 67.86 Favored 'General case' 0 N--CA 1.525 3.283 0 CA-C-N 118.346 0.521 . . . . 1.17 110.477 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -64.89 -33.54 76.25 Favored 'General case' 0 N--CA 1.527 3.415 0 CA-C-N 118.484 0.584 . . . . 0.52 110.064 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -90.01 -34.04 16.13 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-N 117.97 0.35 . . . . 1.53 110.272 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.9 m -73.22 -53.59 10.54 Favored 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 118.535 0.607 . . . . 0.49 109.857 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -77.79 159.12 77.14 Favored Pre-proline 0 N--CA 1.525 3.293 0 N-CA-C 109.102 -0.703 . . . . 0.81 109.102 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' O ' HMC3 ' A' ' 83' ' ' HEC . 37.9 Cg_endo -76.72 65.17 7.56 Favored 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 122.164 1.909 . . . . 0.46 111.257 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.4 m -105.62 -43.86 4.82 Favored 'General case' 0 N--CA 1.522 3.145 0 N-CA-C 108.328 -0.99 . . . . 0.29 108.328 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.13 -18.83 64.81 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 112.627 0.603 . . . . 0.41 112.627 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.83 89.16 Favored 'General case' 0 N--CA 1.528 3.429 0 CA-C-N 119.176 0.898 . . . . 0.31 110.697 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -98.61 -44.2 6.54 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 109.425 -0.583 . . . . 0.24 109.425 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -79.83 158.08 26.87 Favored 'General case' 0 N--CA 1.526 3.372 0 CA-C-O 121.128 0.49 . . . . 0.39 111.858 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.59 175.59 8.44 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 109.273 -0.64 . . . . 1.41 109.273 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.98 -31.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 O-C-N 121.758 -0.589 . . . . 0.51 112.125 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.41 -61.91 1.3 Allowed 'General case' 0 N--CA 1.521 3.091 0 CA-C-N 119.125 0.875 . . . . 2.02 111.665 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 m -93.65 155.86 17.03 Favored 'General case' 0 N--CA 1.53 3.543 0 CA-C-N 118.482 0.583 . . . . 1.15 110.896 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -78.44 135.67 37.45 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.087 -0.383 . . . . 1.1 110.208 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 28.9 mtt -99.41 -64.47 1.04 Allowed 'General case' 0 N--CA 1.522 3.132 0 N-CA-C 107.428 -1.323 . . . . 1.95 107.428 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.49 -43.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.325 0 N-CA-C 108.498 -0.927 . . . . 0.53 108.498 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.15 -149.79 11.12 Favored Glycine 0 N--CA 1.511 3.65 0 N-CA-C 108.991 -1.644 . . . . 0.5 108.991 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.87 154.41 26.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.743 2.295 . . . . 0.31 111.576 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.55 167.42 10.99 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 109.102 -0.703 . . . . 0.22 109.102 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.2 mt -63.21 -38.97 93.26 Favored 'General case' 0 N--CA 1.528 3.46 0 O-C-N 121.651 -0.655 . . . . 0.49 109.715 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -66.29 -33.19 75.19 Favored 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 122.618 0.367 . . . . 1.41 110.22 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.77 -48.15 48.66 Favored 'General case' 0 N--CA 1.524 3.238 0 CA-C-N 118.021 0.373 . . . . 1.32 110.483 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.26 -31.51 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.37 0.532 . . . . 0.47 110.664 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.98 -31.87 50.99 Favored 'General case' 0 N--CA 1.52 3.036 0 CA-C-N 118.003 0.365 . . . . 0.39 110.374 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.5 -45.04 61.28 Favored 'General case' 0 N--CA 1.524 3.245 0 CA-C-N 118.224 0.466 . . . . 0.44 110.585 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -74.53 -47.3 33.68 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 109.048 -0.723 . . . . 2.34 109.048 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -112.39 93.69 4.56 Favored 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 107.244 -1.391 . . . . 1.25 107.244 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.97 74.26 1.45 Allowed 'General case' 0 N--CA 1.518 2.962 0 CA-C-O 121.603 0.716 . . . . 0.65 110.022 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.12 66.11 2.55 Favored Glycine 1 N--CA 1.518 4.1 0 N-CA-C 110.436 -1.066 . . . . 0.7 110.436 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.4 143.62 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 CA-C-N 117.396 0.598 . . . . 1.0 109.492 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.38 139.38 44.04 Favored 'General case' 0 N--CA 1.525 3.279 0 N-CA-C 108.576 -0.898 . . . . 2.9 108.576 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.73 -47.26 1.11 Allowed Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.083 -2.007 . . . . 0.62 108.083 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -38.83 88.13 Favored 'General case' 0 N--CA 1.518 2.973 0 CA-C-N 117.387 0.593 . . . . 0.4 109.574 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.66 83.61 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-N 118.221 0.464 . . . . 0.43 110.228 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.46 -38.5 59.59 Favored 'General case' 0 N--CA 1.522 3.142 0 N-CA-C 109.614 -0.513 . . . . 1.5 109.614 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -69.83 -38.46 76.54 Favored 'General case' 0 N--CA 1.528 3.44 0 N-CA-C 109.236 -0.653 . . . . 0.52 109.236 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.42 -35.88 68.46 Favored 'General case' 0 N--CA 1.523 3.215 0 N-CA-C 109.465 -0.569 . . . . 1.21 109.465 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.04 66.79 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-N 117.97 0.35 . . . . 0.32 110.075 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.82 -28.5 61.65 Favored 'General case' 0 N--CA 1.526 3.345 0 N-CA-C 109.687 -0.486 . . . . 0.7 109.687 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.86 -38.48 83.17 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 122.756 0.422 . . . . 0.34 110.643 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.424 HD12 HG11 ' A' ' 66' ' ' VAL . 42.1 pt -78.29 -23.01 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.573 0 O-C-N 122.049 -0.407 . . . . 0.36 111.382 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -90.35 -32.33 16.52 Favored 'General case' 0 N--CA 1.52 3.025 0 CA-C-N 118.521 0.6 . . . . 1.27 110.671 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -108.73 -58.83 1.96 Allowed 'General case' 0 N--CA 1.522 3.148 0 CA-C-N 118.693 0.678 . . . . 1.63 110.096 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.97 148.99 5.27 Favored Glycine 1 N--CA 1.52 4.278 0 N-CA-C 110.719 -0.953 . . . . 0.44 110.719 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -105.72 141.93 36.31 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 122.27 -0.547 . . . . 0.43 110.117 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -133.67 102.84 5.63 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 109.642 -0.503 . . . . 2.48 109.642 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.78 79.82 0.3 Allowed Glycine 1 N--CA 1.517 4.065 0 O-C-N 121.757 -0.589 . . . . 0.48 112.217 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.77 -42.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 CA-C-N 117.56 0.68 . . . . 0.4 110.361 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -115.77 -52.27 2.63 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.507 0.594 . . . . 0.59 109.92 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.07 -172.1 12.45 Favored Glycine 1 N--CA 1.517 4.077 0 N-CA-C 111.741 -0.544 . . . . 0.8 111.741 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.95 -24.73 9.58 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.111 2.541 . . . . 1.29 112.728 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.463 ' O ' HMD1 ' A' ' 83' ' ' HEC . 38.7 mm -79.52 129.05 73.02 Favored Pre-proline 0 N--CA 1.524 3.246 0 CA-C-O 118.31 -0.852 . . . . 1.0 109.448 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.74 164.83 9.07 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.785 2.323 . . . . 0.68 110.83 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.8 ttp -120.38 131.64 24.38 Favored Pre-proline 0 N--CA 1.522 3.155 0 CA-C-O 118.648 -0.691 . . . . 0.36 109.429 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.52 172.19 15.61 Favored 'Trans proline' 0 CA--C 1.574 2.507 0 C-N-CA 122.681 2.254 . . . . 0.41 110.58 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -71.88 110.39 2.9 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.235 1.956 . . . . 0.36 110.181 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -81.67 157.27 69.84 Favored Pre-proline 0 N--CA 1.524 3.231 0 CA-C-O 119.108 -0.472 . . . . 0.46 110.817 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.33 99.9 1.31 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.502 2.134 . . . . 0.48 109.761 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 48' ' ' ILE . 12.7 p -151.1 133.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 N-CA-C 109.795 -0.446 . . . . 0.43 109.795 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 p -89.83 -178.33 5.47 Favored 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 122.469 0.307 . . . . 0.97 110.362 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.83 -44.84 84.36 Favored 'General case' 0 N--CA 1.527 3.424 0 O-C-N 121.697 -0.627 . . . . 1.97 110.699 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.79 -36.01 79.68 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-N 118.173 0.442 . . . . 1.11 110.894 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -73.16 -38.13 66.32 Favored 'General case' 0 N--CA 1.521 3.114 0 N-CA-C 109.47 -0.567 . . . . 1.23 109.47 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.25 73.63 Favored 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 118.006 0.366 . . . . 0.47 110.726 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -73.74 -40.8 63.26 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-N 118.297 0.499 . . . . 2.81 109.738 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 53.6 mt -72.25 -38.95 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.849 -0.797 . . . . 1.45 108.849 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.439 HD23 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -71.14 -39.51 71.92 Favored 'General case' 0 N--CA 1.523 3.222 0 N-CA-C 109.491 -0.559 . . . . 1.67 109.491 179.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.12 -41.92 85.35 Favored 'General case' 0 N--CA 1.524 3.23 0 CA-C-N 118.179 0.445 . . . . 0.58 110.101 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.4 -28.65 64.16 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 121.99 -0.444 . . . . 1.62 110.557 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 31.6 t90 -77.5 -43.4 32.24 Favored 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 118.613 0.642 . . . . 0.54 110.274 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.91 -31.26 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.851 0 CA-C-N 118.838 0.744 . . . . 0.49 109.9 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.4 mt -76.51 -49.54 16.25 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.609 -0.886 . . . . 0.84 108.609 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.2 m -118.05 97.35 5.77 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.655 -1.239 . . . . 0.83 107.655 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.88 156.38 22.45 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 121.895 -0.503 . . . . 1.14 111.189 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm . . . . . 0 N--CA 1.517 2.922 0 CA-C-O 118.625 -0.702 . . . . 3.79 109.51 179.736 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HEC . . . . . 0.463 HMD1 ' O ' ' A' ' 59' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_